Core Viewpoint - Since the implementation of the comprehensive registration system, 10 IPO applications have been penalized with disqualifications ranging from 1 to 5 years due to violations during the review process, primarily involving false financial data and internal control issues [1][2] Group 1: Regulatory Environment - The current regulatory environment in the A-share market emphasizes strict supervision and enforcement, particularly under the leadership of the current chairman of the China Securities Regulatory Commission (CSRC), Wu Qing [1] - The CSRC has intensified its enforcement efforts in key areas such as issuance and listing, information disclosure, mergers and acquisitions, and delisting, focusing on fraudulent issuance and financial fraud [1][2] Group 2: Violations and Penalties - A total of 10 companies have received disqualifications for their IPO applications due to various violations, including false financial records and issues related to internal controls and R&D personnel recognition [1][2] - Specific cases include: - **Sierxin**: Received a 5-year disqualification for fabricating significant false content in its securities issuance documents, inflating revenue by 1,536.72 million yuan, which accounted for 11.55% of its total revenue for the year [5][6] - **Huadao**: Also received a 5-year disqualification for falsifying sales through fake invoices, inflating sales revenue by 25.6 million yuan in 2019, which was 10.87% of the reported sales for that year [10][11] - **Kuntengwei**: Received a 5-year disqualification for failing to disclose important facts regarding share transfer prices, leading to a profit inflation of 3,200 million yuan, which was 61.13% of its total profit for 2020 [14] Group 3: Specific Violations - Violations related to financial data falsification and internal control issues have been identified in 7 of the penalized companies, with significant penalties imposed [4] - Companies like **Xiangnian Food** faced severe penalties for obstructing on-site inspections and destroying evidence, resulting in a 5-year disqualification [21][23] - **LianGang Optoelectronics** and **Guohong Tools** faced penalties for issues related to R&D personnel recognition and internal control deficiencies, with LianGang receiving an 18-month disqualification [15][19]

答：《监管规则适用指引——发行类第9号：研发人员及研发投入》明确，对于既从事研发活动又从事非研发活动的非全时研发人员，当期研发工时占比低 于50%的，原则上不应认定为研发人员。审核实践发现，部分发行人存在人员内部调岗、员工实际从事活动与工作关系所属部门不一致、将实习期等纳入 工时统计等情形。对于上述情形，在进行研发人员认定时应重点把握以下方面： 文/梧桐小新 2023年2月上交所实施全面注册制后，将原分期发布的《科创板发行上市审核动态》变更为《上交所发行上市审核动态》。2023年至今，《上交所发行上市审核 动态》已发布13期，本文将这13期中42个"问题解答"汇总，供读者们分享、收藏。 | 期数 | 间题解答 | | --- | --- | | 2025年第1期 | 1、 研发人员认定注意事项 | | | 涉产学研合作技术成果的核查要求 2、 | | | 3、再融资项目中介机构违法违规的核查要求 | | | 4、股份支付授予日的认定 | | 2024年第6期 | 1、并购重组项目预沟通的注意事项 | | | 2、再融资募集资金投向的披露和说明注意事项 | | | 3、主板板块定位条件中行业代表性的关注要点 | ...